Loading
Latest filing published 18 Nov 2025 for Xvivo Perfusion Aktiebolag, €22k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Lena Hagman is a declared insider of Xvivo Perfusion Aktiebolag (senior executive), with filings sourced from Finansinspektionen. In total, 2 filings cover trades dated from 28 April 2025 to 18 November 2025.
The open-market record is one-sided, with 2 purchases worth €65k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 18 November 2025: an open-market purchase of €22k, in Xvivo Perfusion Aktiebolag. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration